Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 63629-1094
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
Figure 2 (Spironolactone 03)
This appears to be a table of medical data, including information about a subgroup, creatinine, diabetes, potassium, and beta blockers. There is also a graph comparing spironolactone to placebo, with differing effectiveness over time.*
Lbl636291094
This is the label for NILD's Spironolactone Tablets, USP. Each tablet contains 100 mg of spironolactone. It should be stored at 20° to 25°C (68° to 77°F) and kept out of the reach of children. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The label also includes the NDC number as well as information about the manufacturer (PHARMACEUTICALS) and the quantity (500 tablets).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
